Asymmetric synthesis of a potent azepanone-based inhibitor of the cysteine protease cathepsin K

In this account we detail the asymmetric synthesis of 1, a potent azepanone-based inhibitor of cathepsin K (Ki = 0.16 nM), which has been shown to inhibit the production of biomarkers of bone resorption in monkeys. The key steps in the synthesis sequence were the utility of the Evans aldol reaction coupled with the ring closing olefin metatheses to assemble the azepanone core contained within 1.